Free Trial

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation logo
GBX 1,500.48 +2.28 (+0.15%)
As of 05/21/2025 04:31 AM Eastern

FBT vs. TRST, PRSM, KAPE, KNOS, LTG, ALFA, GBG, ATG, CER, and IMO

Should you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Trustpilot Group (TRST), Blue Prism Group (PRSM), Kape Technologies (KAPE), Kainos Group (KNOS), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), Auction Technology Group (ATG), Cerillion (CER), and IMImobile (IMO). These companies are all part of the "software - application" industry.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Trustpilot Group (LON:TRST) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, community ranking, profitability, media sentiment and institutional ownership.

Trustpilot Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,364.07
Trustpilot Group£222.55M5.61£20.08M£3.0278.96

Trustpilot Group has a net margin of 9.02% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. Trustpilot Group's return on equity of 29.53% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.

Company Net Margins Return on Equity Return on Assets
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A
Trustpilot Group 9.02%29.53%1.45%

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation received 47 more outperform votes than Trustpilot Group when rated by MarketBeat users. However, 75.76% of users gave Trustpilot Group an outperform vote while only 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote.

CompanyUnderperformOutperform
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes
72
66.67%
Underperform Votes
36
33.33%
Trustpilot GroupOutperform Votes
25
75.76%
Underperform Votes
8
24.24%

In the previous week, Trustpilot Group had 2 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 2 mentions for Trustpilot Group and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. Trustpilot Group's average media sentiment score of 0.30 beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's score of 0.00 indicating that Trustpilot Group is being referred to more favorably in the news media.

78.2% of Trustpilot Group shares are owned by institutional investors. 8.2% of Trustpilot Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Trustpilot Group has a consensus price target of GBX 335, suggesting a potential upside of 40.64%. Given Trustpilot Group's stronger consensus rating and higher possible upside, analysts plainly believe Trustpilot Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Trustpilot Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Trustpilot Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 14 of the 15 factors compared between the two stocks.

Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBT vs. The Competition

MetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON Exchange
Market Cap£615.52M£5.34B£25.10B£2.66B
Dividend YieldN/A3.20%2.90%5.05%
P/E Ratio-1,364.0728.5044.59134.04
Price / SalesN/A276.191,997.44215,627.72
Price / Cash3.5416.6334.7828.02
Price / BookN/A9.636.653.80
Net IncomeN/A£63.43M£739.99M£5.88B
7 Day Performance5.27%0.53%-0.92%0.50%
1 Month Performance7.70%12.84%12.60%21.94%
1 Year Performance0.86%9.60%52,628.86%119.00%

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBT
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
N/AGBX 1,500.48
+0.2%
N/A+2.3%£615.52MN/A-1,364.0720
TRST
Trustpilot Group
2.0884 of 5 stars
GBX 252.20
+0.1%
GBX 335
+32.8%
+11.7%£1.32B£222.55M83.60820
PRSM
Blue Prism Group
N/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading Volume
KAPE
Kape Technologies
N/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap Down
KNOS
Kainos Group
3.3235 of 5 stars
GBX 815
+0.8%
GBX 1,070
+31.3%
-41.5%£1.03B£383.18M21.362,953News Coverage
Earnings Report
Analyst Forecast
LTG
Learning Technologies Group
N/AN/AGBX 90
+∞
N/A£792.10M£529.20M16.755,001
ALFA
Alfa Financial Software
N/AGBX 242.50
+1.9%
N/A+41.9%£726.24M£103.11M32.78475Gap Up
GBG
GB Group
2.1311 of 5 stars
GBX 280.50
+1.6%
GBX 395
+40.8%
-20.1%£707.49M£276.95M-14.561,183News Coverage
ATG
Auction Technology Group
1.6033 of 5 stars
GBX 547
-1.1%
GBX 680
+24.3%
-23.7%£675.74M£136.68M66.81396
CER
Cerillion
2.5314 of 5 stars
GBX 1,730
+0.6%
N/A+18.8%£513.04M£41.39M36.47321Earnings Report
Dividend Increase
Analyst Forecast
High Trading Volume
IMO
IMImobile
N/AN/AN/AN/A£490.40M£164.04M123.755,300

Related Companies and Tools


This page (LON:FBT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners